Exact Mass: 395.1052

A hydroxycoumarin that is the aglycone of novobiocin.

Gonyautoxin II

{4-[(carbamoyloxy)methyl]-10,10-dihydroxy-2,6-diimino-hexahydro-1H-pyrrolo[1,2-c]purin-9-yl}oxidanesulfonic acid

Gonyautoxin III is found in mollusks. Gonyautoxin III is from Gonyaulax and Protogonyaulax species. From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

Toxin b2

Gonyautoxin 6; Gonyautoxin VI; GTX6; Toxin B2

D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

Bay 41-4109 racemate

C18H13ClF3N3O2 (395.0648)

Gonyautoxin VI

N-SulphO({5,10,10-trihydroxy-2,6-diimino-decahydropyrrolo[1,2-c]purin-4-yl}methoxy)carboximidic acid

Gonyautoxin VI is found in mollusks. Gonyautoxin VI is produced by Gonyaulax and Protogonyaulax species, isolated from shellfish. Neurotoxin; causal agent with Saxitoxin, of shellfish poisoning. Production by Gonyaulax and Protogonyaulax subspecies, isolated from shellfish. Neurotoxin; causal agent with Saxitoxin, of shellfish poisoning. Gonyautoxin VI is found in mollusks.

1,1-Diphenyl-2-picrylhydrazine

1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine

C18H13N5O6 (395.0866)

2,5-Dimethylcelecoxib

4-[5-(2,5-dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

C18H16F3N3O2S (395.0915)

Balaglitazone

5-({4-[(3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione

C20H17N3O4S (395.094)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent Balaglitazone is a selective partial PPARγ agonist with an EC50 of 1.351 μM for human PPARγ.

5-Pyrimidinecarboxylic acid, 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-1,4-dihydro-6-methyl-, methyl ester, (4R)-

C18H13ClF3N3O2 (395.0648)

Guanidine, N-(4-chlorophenyl)-N'-cyano-N'-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-, trans-

Guanidine, N-(4-chlorophenyl)-N-cyano-N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-, trans-

C20H18ClN5O2 (395.1149)

Cloricromen

Ethyl 2-({8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-chromen-7-yl}oxy)acetic acid

C20H26ClNO5 (395.1499)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

N-(2,5-Dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide

N-[(2,5-dimethoxyphenyl)methyl]-N-(5-fluoro-2-phenoxyphenyl)acetamide

C23H22FNO4 (395.1533)

DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor. Target:PBR in vitro: DAA1106 binding to PBR was significantly increased in widespread areas in MCI subjects when compared to healthy controls.[1] DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. [2] in vivo: DAA-1106 has anxiolytic effects in animal studies. DAA-1106 has a sub-nanomolar binding affinity (Ki) of 0.28nM, and has been used extensively in its 3H or 11C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease. [2]

Morniflumate

2-(morpholin-4-yl)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylate

C19H20F3N3O3 (395.1457)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

Imidodicarbonimidic diamide, N-(1-methylethyl)-N'-(3-(2,4,5-trichlorophenoxy)propoxy)-, hydrochloride

1-{[amino({[3-(2,4,5-trichlorophenoxy)propoxy]amino})methylidene]amino}-N-(propan-2-yl)methanimidamide

C14H20Cl3N5O2 (395.0683)

M1

N-SulphO({9,10,10-trihydroxy-2,6-diimino-decahydropyrrolo[1,2-c]purin-4-yl}methoxy)carboximidic acid

Basic protein, MW 5677 Da. A gamma-thionin showing antifungal activity. Isolated from seeds of yellow mustard, Sinapis alba. [CCD]. M1 is found in brassicas.

Benzomalvin C

(2S,3S)-6-Methyl-3-phenyl-13H-spiro[oxirane-2,7-quinazolino[3,2-a][1,4]benzodiazepine]-5,13(6H)-dione

Dehydrosaulatine

7-hydroxy-1-(1-hydroxyethyl)-8-methyl-2,3,8,9a,10,12a-hexahydro-6H-benzo[cd]furo[2,3:5,6]pyrano[3,4-g]pyrrolo[1,2-a]indole-6,11(1H)-dione

spiro[(5S)-3-methoxy-2-cyclopenten-1-one-5:3(2S)-2-chloro-3aS,7aS-((2,3)-1-methylpyrrolidine)-6,7-dimethoxy-1,2,3,3a,4,7a-hexahydro-4H,5H-inden-4,5-dione]

C19H22ClNO6 (395.1136)

2-(4-hydroxybenzoyloxymethyl)-4-O-beta-D-glucopyranosyloxy-2(E)-butenenitrile|nigrumin-4-hydroxy-benzoate

C18H21NO9 (395.1216)

4,9,10,11-tetramethoxy-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-8-one|Ocominaron|Ocominarone

C21H17NO7 (395.1005)

5-[(6,7-Dimethoxyisoquinolin-1-yl)carbonyl]-1,3-benzodioxole-4-carboxylic acid methyl ester

C21H17NO7 (395.1005)

3-Methyl-3-(6,7-dimethoxyisoquinoline-1-yl)-4,7-dimethoxyisobenzofuran-1(3H)-one

conithiaquinone A

C19H25NO6S (395.1403)

C21H17NO7

C21H17NO7 (395.1005)

11Beta-hydroxy-N21-sulfocarbamoyl-saxitoxin|M1

SCHEMBL4045784

cardiospermin-5-(4-hydroxy) benzoate|Cardiospermin-5-(4-hydroxy)benzoate

C18H21NO9 (395.1216)

Asp Asp Phe

Met Asp Met

Met Met Asp

Cys His His

Cyclonovobiocic Acid

Phe Asp Asp

3-(6,7-Dimethoxy-isoquinolin-1-yl)-3-(3,4-dimethoxy-phenyl)-acrylic acid

"NCGC00160257-01!3-(6,7-Dimethoxy-isoquinolin-1-yl)-3-(3,4-dimethoxy-phenyl)-acrylic acid"

Benzomalvin C_120256

C24H17N3O3_Spiro[oxirane-2,7(13H)-quinazolino[3,2-a][1,4]benzodiazepine]-5,13(6H)-dione, 6-methyl-3-phenyl-, (2S,3S)

NCGC00180312-03_C24H17N3O3_Spiro[oxirane-2,7(13H)-quinazolino[3,2-a][1,4]benzodiazepine]-5,13(6H)-dione, 6-methyl-3-phenyl-, (2S,3S)-

(2S,3S)-6-methyl-3-phenylspiro[oxirane-2,7-quinazolino[3,2-a][1,4]benzodiazepine]-5,13-dione

Cys Cys Gly Asn

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

Cys Cys Asn Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetic acid

Cys Gly Cys Asn

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Cys Gly Asn Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Cys Asn Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetic acid

Cys Asn Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoic acid

Gly Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Gly Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Gly Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

Asn Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

Asn Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

Asn Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

Cys His His

C15H21N7O4S1 (395.1376)

His Cys His

C15H21N7O4S1 (395.1376)

Asp Phe Asp

His His Cys

C15H21N7O4S1 (395.1376)

Asp Met Met

Deschlorobenzoyl Indomethacin glucuronide

C18H21NO9 (395.1216)

N-(4,7-Dihydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-2,2-dimethylchromane-6-carboxamide

[4-(2,4-difluorophenyl)-2-[(2,5-dimethylphenyl)carbamoyl]phenyl] acetate

C23H19F2NO3 (395.1333)

(S)-2-Benzyloxycarbonylamino-1,4-bis(methanesulf

C14H21NO8S2 (395.0709)

Z-Trp-Gly-OH

6-(3-chloropropoxy)-N- (3-chloro-4-fluorophenyl)-7-Methoxyquinazolin-4-aMine

C18H16Cl2FN3O2 (395.0604)

tert-butyl 7-bromo-4-oxospiro[3H-chromene-2,4-piperidine]-1-carboxylate

C18H22BrNO4 (395.0732)

Fmoc-D-Asp(OAll)-OH

4-[((2R)-Hydroxy-3-phthalimido)propylamine]phenyl-3-morpholinone

tert-Butyl ((diphenylphosphoryl)methyl)sulfonylcarbamate

C18H22NO5PS (395.0956)

tert-Butyl 6-bromo-4-oxospiro[chroman-2,4-piperidine]-1-carboxylate

C18H22BrNO4 (395.0732)

Lobaplatin

C9H16N2O3Pt (395.0809)

n-benzoyl-dl-phenylalanine 2-naphthyl ester

C26H21NO3 (395.1521)

Grepafloxacin hydrochloride

C19H23ClFN3O3 (395.1412)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

Gonyautoxin III

K-115

Ripasudil hydrochloride dihydrate

C15H23ClFN3O4S (395.1082)

5-[3-(Trifluoroacetamido)-1-(E)-propenyl]-uridine

C14H16F3N3O7 (395.094)

n-benzoyl-dl-phenylalanine 2-naphthyl ester [for determination of chymotrypsin]

C26H21NO3 (395.1521)

KU-55933

2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one

C21H17NO3S2 (395.065)

Fmoc-Asp-OAll

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)BUTANE-1,4-DIYL DIMETHANESULFONATE

C14H21NO8S2 (395.0709)

Orbifloxacin

C19H20F3N3O3 (395.1457)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

N-CBZ-N,N-BIS{2-[(METHYLSULFONYL)OXY]ETHYL}-AMINE

C14H21NO8S2 (395.0709)

2-AMINO-5,7-DIPHENYL-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID EHYL ESTER

C22H21NO2S2 (395.1014)

[4-(2,4-difluorophenyl)-2-(propylcarbamoyl)phenyl] benzoate

C23H19F2NO3 (395.1333)

Fmoc-Asp(OAll)-OH

2-benzyl-1-(2-hydroxyethyl)-3-[(2-methyl-1H-indol-3-yl)azo]-1H-pyrazolium chloride

C21H22ClN5O (395.1513)

dea-c8-18 perfluoroalkylethyl phosphate

C10H20F6NO6P (395.0932)

4-Benzyloxy-2-(2carbomethoxy)thiophenylnitrobenzene

C21H17NO5S (395.0827)

(2R,3R,4S,5R)-2-(6-amino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol

C13H16F3N5O4S (395.0875)

Oxazine 4 perchlorate

C18H22ClN3O5 (395.1248)

2-(2-ethylhexyl)-4,7-di-(thiophene-2-yl)-2,1,3-benzotriazole

C22H25N3S2 (395.149)

(2E)-2-Methyl-4-(9H-purin-6-ylamino)-2-buten-1-yl beta-D-glucopyranosiduronic acid

C16H21N5O7 (395.1441)

5-[3-(TERT-BUTYL)-1-(2,4-DICHLOROBENZYL)-1H-PYRAZOL-5-YL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

C17H19Cl2N5S (395.0738)

1-tert-Butyl 4-(pentafluorophenyl) piperidine-1,4-dicarboxylate

C17H18F5NO4 (395.1156)

Imidodicarbonimidic diamide, N-(1-methylethyl)-N-(3-(2,4,5-trichlorophenoxy)propoxy)-, hydrochloride

C14H20Cl3N5O2 (395.0683)

D007004 - Hypoglycemic Agents > D001645 - Biguanides

N-(4,6-dimethyl-2-pyridinyl)-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarbothioamide

C18H20F3N5S (395.1391)

methyl 5-[(E)-(tert-butylcarbamothioylhydrazinylidene)methyl]-1-(2,4-difluorophenyl)pyrazole-4-carboxylate

C17H19F2N5O2S (395.1227)

(E)-2-Benzylidene-5-bromo-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one

C22H22BrNO (395.0885)

2-(6-{[(3-Chloro-2-Methylphenyl)sulfonyl]amino}pyridin-2-Yl)-N,N-Diethylacetamide

C18H22ClN3O3S (395.107)

(2r,3r)-7-(Methylsulfonyl)-3-(2,4,5-Trifluorophenyl)-1,2,3,4-Tetrahydropyrido[1,2-A]benzimidazol-2-Amine

C18H16F3N3O2S (395.0915)

1-[(1S)-Carboxy-2-(methylsulfinyl)ethyl]-(3R)-[(5S)-5-amino-5-carboxypentanamido]-(4R)-sulfanylazetidin-2-one

C13H21N3O7S2 (395.0821)

Morniflumate

C19H20F3N3O3 (395.1457)

Cloricromen

Cloricromene

C20H26ClNO5 (395.1499)

(2,6-diamino-9,10,10-trihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methoxycarbonylsulfamic acid

Guanidine, N-(4-chlorophenyl)-N'-cyano-N'-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-, trans-

Guanidine, N-(4-chlorophenyl)-N-cyano-N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-, trans-

C20H18ClN5O2 (395.1149)

Aklanonate

C21H15O8- (395.0767)

(2E,6E,10E)-omega-hydroxyfarnesyl diphosphate(3-)

C15H25O8P2-3 (395.1025)

Rot-2-enonate

C23H23O6- (395.1495)

(S)-farnesyl thiopyrophosphate

C15H25O6P2S-3 (395.0847)

beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-hydroxyproline

(4S)-4-[(2S,3R,4S,5S)-3-[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrrolidine-2-carboxylic acid

Gonyautoxin 2

D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

Nogalaviketone(1-)

C21H15O8- (395.0767)

A phenolate anion obtained by deprotonation of the 5-OH group of nogalaviketone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

5-(4-chlorophenyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-furancarboxamide

C22H22ClN3O2 (395.14)

4-[3-(3-Fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide

C21H18FN3O2S (395.1104)

Asp-Asp-Phe

GPL-25 terminal disaccharide

Methyl nogalonate(1-)

C21H15O8- (395.0767)

6-Amino-1,3-dimethyl-5-[(3-methyl-1-phenyl-5-thieno[2,3-c]pyrazolyl)-oxomethyl]pyrimidine-2,4-dione

C19H17N5O3S (395.1052)

2-(3-Chlorophenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester

C22H18ClNO4 (395.0924)

5-[(2-Fluorophenyl)methyl]-6,11-dioxo-3-benzo[b][1,4]benzothiazepinecarboxylic acid

C21H14FNO4S (395.0628)

4-(2,4-Dichlorophenoxy)butanoic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester

C19H19Cl2NO4 (395.0691)

1-(1,3-Benzodioxol-5-yl)-3-[4-(4-hydroxyphenyl)piperazin-1-yl]pyrrolidine-2,5-dione

2-(3,4-Dimethoxyphenyl)-9-(4-fluorophenyl)-2,3-dihydropurine-6-carboxamide

C20H18FN5O3 (395.1394)

N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide

C16H17N3O5S2 (395.061)

2-[(4E)-4-[(3-ethoxy-4-hydroxyphenyl)methylidene]-2,5-dioxoimidazolidin-1-yl]-N-(3-methylphenyl)acetamide

1-[4-Chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea

C17H18ClN3O4S (395.0706)

3-Hydroxy-1-adamantanecarboxylic acid [2-[2-(difluoromethoxy)anilino]-2-oxoethyl] ester

C20H23F2NO5 (395.1544)

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(4-morpholinyl)-4-oxazolecarbonitrile

C21H18ClN3O3 (395.1037)

3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide

C17H21N3O4S2 (395.0973)

3-(3-Chloro-2-methylphenyl)-1-[(4-methylphenyl)methyl]-1-(3-pyridinylmethyl)thiourea

C22H22ClN3S (395.1223)

2-(2-methoxyethyl)-9-methyl-1-oxo-N-(thiophen-2-ylmethyl)-4-pyrido[3,4-b]indolecarboxamide

C21H21N3O3S (395.1304)

1-[1-(4-Methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone

N-[3-(3-chlorophenyl)phenyl]-1-(3-isoxazolylmethyl)-4-piperidinecarboxamide

C22H22ClN3O2 (395.14)

2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(4-methyl-2-thiazolyl)acetamide

C19H17N5OS2 (395.0874)

(5-Chloro-2-hydroxyphenyl)-[2-ethyl-3-(4-fluorophenyl)-6-pyrazolo[1,5-a]pyrimidinyl]methanone

C21H15ClFN3O2 (395.0837)

2-[[5-(4-methylphenyl)-3-thiazolo[2,3-c][1,2,4]triazolyl]thio]-N-(6-methyl-2-pyridinyl)acetamide

C19H17N5OS2 (395.0874)

Asp-Phe-Asp

His-His-Cys

Cys-His-His

His-Cys-His

3,6-Diamino-10-(3-carboxypropyl)acridinium perchlorate

C17H18ClN3O6 (395.0884)

(1S,9R,10R,11R)-12-(cyclopropanecarbonyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid

(1R,9S,10S,11S)-12-(cyclopropanecarbonyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid

Phe-Asp-Asp

Asp-Met-Met

Met-Asp-Met

Met-Met-Asp

Tetraethyl [(3-hydroxy-2-pyridyl)amino]methanediphosphonate

C15H27NO7P2 (395.1263)

2-(Acetylamino)-4-O-[(4,5-didehydro-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

Delta(4)-beta-D-GlcpA-(1->4)-alpha-D-GlcpNAc

beta-L-thrHexpA4en-(1->4)-beta-D-GlcpNAc

(2R,3R,4R)-2-[(2R,3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(E)-3-(6,7-dimethoxyisoquinolin-1-yl)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid

2-Me-alpha-D-Fucp4NAc-(1->4)-beta-D-GlcpA

An amino disaccharide consisting of beta-D-glucopyranuronic acid having a 4-acetamido-4,6-dideoxy-2-O-methyl-alpha-L-galactopyranosyl attached at the 4-position.

BE-54238B